$SRPT

Seeing a lot of folks trying to handicap $SRPT “base biz”/exon skipping valuation That “base biz” could potentially evaporate in approx a year when the ESSENCE confirmatory study for Vyondys/Amondys reads out (like all of SRPT drugs, it’ll likely fail as well) https://t.co/5eX2S2JfRB Of course, this is SRPT so it’s a valid question if they’ll actually ever announce the results